MedPath

Comparison of Sequential therapy for eradication of H. Pylori infection in renal failure patients

Phase 2
Conditions
Helicobacter pylori infection.
Helicobacter pylori
Registration Number
IRCT201201231241N3
Lead Sponsor
Department of Research and Technology, Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

patients with dyspepsia symptoms over the past one month from gastroenterology or nephrology clinic or hospital dialysis ward who have infection with H. Pylori confirmed by rapid urease test and biopsy in endoscopy. Exclusion Criteria : taking antibiotic regimen to eradicate H. pyloriand or receiving proton pump inhibitors, Bismuth, or NSAID during the last month; concomitant anticoagulant, corticosteroid or Ketoconazole; history of gastric or esophageal surgery; sensitivity to antibiotics; negative endoscopic biopsy; drinking alcohol and smoking; pregnancy and lactation; severe heart disease; diseases of the thyroid gland or liver cancer; chronic renal failure patients who are prior to stage 5 or have not received renal replacement therapy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Eradication of Helicobacter pylori Infection. Timepoint: At the end of four weeks after treatment. Method of measurement: Urea Test.;Eradication of Helicobacter pylori Infection. Timepoint: At the end of four weeks after treatment. Method of measurement: Creatinine Clearance Test.;Eradication of Helicobacter pylori Infection. Timepoint: At the end of four weeks after treatment. Method of measurement: Stool examination.;Eradication of Helicobacter pylori Infection. Timepoint: At the end of four weeks after treatment. Method of measurement: Biopsy by Endoscopic.
Secondary Outcome Measures
NameTimeMethod
Acute Renal Failure. Timepoint: At the first and second weeks of treatment. Method of measurement: Testing Urea.;Acute Renal Failure. Timepoint: At the first and second weeks of Treatment. Method of measurement: creatinine clearance test.;Acute Renal Failure. Timepoint: at the first and second weeks of treatment. Method of measurement: weight.
© Copyright 2025. All Rights Reserved by MedPath